In addition to biopsies, tracking gradual increases in blood levels of neuron-specific enolase (NSE) or pro-gastrin-releasing peptide (pro-GRP) can assist in identifying SCLC clones before they become apparent, serving as a supplementary diagnostic tool for SCLC transformation. This evidence concerns the gene GRP and small cell lung carcinoma.